Back to BlackRock, Inc. BlackRock, Inc.

RLMDRLMD
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in RELMADA THERAPEUTICS INC

BlackRock, Inc. holds 7.4M shares of RLMD (RELMADA THERAPEUTICS INC), worth $51.4M as of 2026-Q2. The position was increased (+475.9% shares). RLMD represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$51.4M

Current Shares

7.4M

Total Value Change

+$51.1M

Total Shares Change

+6.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.4M
+475.9%
$51.4M0.0%$6.92
47
2026-Q1
Increased
1.3M
+1.7%
$9M0.0%$4.67
28
2025-Q4
Increased
1.3M
+149.5%
$6.1M0.0%$4.53
44
2025-Q3
Unchanged
508,000
0.0%
$1M0.0%$1.88
0
2025-Q2
Decreased
508,000
-10.4%
$304,9520.0%$0.61
0
2025-Q1
Decreased
566,905
-4.5%
$153,0640.0%$0.30
0
2024-Q4
New
593,326
-
$308,5300.0%$0.46
36

Other major holders of RLMD: RTW INVESTMENTS, LP, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used